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Pericardial Fat Is Independently
Associated With Human Atrial Fibrillation
M. Obadah Al Chekakie, MD, Christine C. Welles, MD, Raymond Metoyer, BSRT,
Ahmed Ibrahim, MD, Adam R. Shapira, MD, Joseph Cytron, MD, Peter Santucci, MD,
David J. Wilber, MD, Joseph G. Akar, MD, PHD
Maywood, Illinois
Objectives The purpose of this study was to investigate the association between atrial fibrillation (AF) and pericardial fat.
Background Pericardial fat is visceral adipose tissue that possesses inflammatory properties. Inflammation and obesity are
associated with AF, but the relationship between AF and pericardial fat is unknown.
Methods Pericardial fat volume was measured using computed tomography in 273 patients: 76 patients in sinus rhythm,
126 patients with paroxysmal AF, and 71 patients with persistent AF.
Results Patients with AF had significantly more pericardial fat compared with patients in sinus rhythm (101.6  44.1 ml
vs. 76.1  36.3 ml, p  0.001). Pericardial fat volume was significantly larger in paroxysmal AF compared with
the sinus rhythm group (93.9  39.1 ml vs. 76.1  36.3 ml, p  0.02). Persistent AF patients had a signifi-
cantly larger pericardial fat volume compared with paroxysmal AF (115.4  49.3 ml vs. 93.9  39.1 ml, p 
0.001). Pericardial fat volume was associated with paroxysmal AF (odds ratio: 1.11; 95% confidence interval:
1.01 to 1.23, p  0.04) and persistent AF (odds ratio: 1.18, 95% confidence interval: 1.05 to 1.33, p  0.004),
and this association was completely independent of age, hypertension, sex, left atrial enlargement, valvular
heart disease, left ventricular ejection fraction, diabetes mellitus, and body mass index.
Conclusions Pericardial fat volume is highly associated with paroxysmal and persistent AF independent of traditional risk factors
including left atrial enlargement. Whether pericardial fat plays a role in the pathogenesis of AF requires future
investigation. (J Am Coll Cardiol 2010;56:784–8) © 2010 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2010.03.071m
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phe association between obesity and cardiovascular disease
s well established (1). Recently, studies have focused on the
elationship between regional fat depots and cardiovascular
isk, independent of total adiposity (2,3). Pericardial fat
erves an important endocrine and inflammatory function,
nd given its direct apposition to myocardium and coronary
rteries, pericardial fat may play a central role in the
athogenesis of cardiovascular disease, mediated by its
nflammatory properties (2,4,5).
Central obesity is associated with atrial fibrillation (AF);
owever, the relationship between visceral adiposity and AF
as not been explored (6–8). Moreover, AF is associated with
nflammation (9,10). Therefore, given the strong association
etween AF, obesity, and inflammation, and given the inflam-
rom the Loyola University Medical Center, Maywood, Illinois. Dr. Al Chekakie is
n the Fellowship advisory council for Biotronik. Dr. Wilber has been an investigator
or Medtronic, St. Jude Medical, Biosense Webster, and Cardio Insight, and has been
consultant for Biosense Webster and Cardio Insight. All other authors have reported
hat they have no relationships to disclose.d
Manuscript received December 28, 2009; revised manuscript received March 3,
010, accepted March 18, 2010.atory characteristics of pericardial adipose tissue and its
elationship to cardiovascular disease, we hypothesized that
ericardial fat is independently associated with AF in humans.
ethods
tudy population. The study was approved by the institu-
ional review board and consisted of 300 consecutive patients
ho underwent computed tomography (CT). This included
18 patients referred for AF ablation and a control group of
atients who underwent cardiac CT for evaluation of poten-
ially cardiac symptoms but were at intermediate risk and had
o history of AF (n  82). Twenty-one patients in the AF
roup were excluded because of image clipping (n  19) or
ignificant motion artifact (n  2). The control group con-
isted of 76 patients, after excluding patients for motion artifact
n  4) and history of heart transplantation (n  2). Body
ass index (BMI) was measured in all patients. Obesity was
efined as BMI 30 kg/m2.
T and pericardial fat measurement. CT studies were
erformed using a 64-slice scanner (Siemens Sensation Car-
iac 64, Siemens Medical Solutions, Malvern, Pennsylvania).
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August 31, 2010:784–8 Pericardial Fat Related to Atrial Fibrillationated studies were performed before ablation using an elec-
rocardiogram-triggered scanning protocol. To ensure
dequate gating and minimal motion artifact, patients in AF
n  73) received beta-blockers and underwent CT scanning
nly if the ventricular response was 80 beats/min. The
ercentage of the R-R interval with the least amount of motion
as used for pericardial fat measurements, which were per-
ormed offline using a semiautomated technique and dedicated
orkstation (Advantage Workstation 4.4, General Electric,
aukesha,Wisconsin). Contiguous 2.0-mm slices of the heart
xtending from the bifurcation of the pulmonary artery to the
iaphragmwere analyzed (average of 45). The pericardiumwas
anually traced, and pericardial fat consisted of all adipose
issue within the pericardial sac, identified by an image display
hreshold setting of190 to30Hounsfield units. Pericardial
at measurements were performed by 2 independent operators.
he interobserver and intraobserver correlations were 0.99 and
.97, respectively (p  0.001). Left atrial volume was calcu-
ated at end systole using a Tera Recon workstation (Tera
econ, San Mateo, California).
chocardiographic measurements. Left atrial diameter
as measured at end systole in the parasternal long-axis view.
eft atrial echocardiographic volume was calculated using the
rea length technique after tracing the left atrial (LA) area in
he 2- and 4-chamber views. Left atrial enlargement was
efined as diameter4.2 cm. Left ventricular ejection fraction
LVEF) was measured using the Simpson method. An LVEF
f 50% was considered abnormal. Structural heart disease
as defined as moderate or greater amount of valvular regur-
itation or left ventricular hypertrophy 1.4 cm.
tatistical analysis. Analysis was done using Stata version
.0 (StataCorp, College Station, Texas). The Student t test
as used to compare baseline continuous variables, and the
hi-square test was used to compare dichotomous variables.
nalysis of variance was used to compare the baseline contin-
ous variables among subgroups, and the chi-square test was
sed for dichotomous variables. Pairwise comparisons are
resented when analysis of variance was significant.
Multivariate linear regression was used to study the associ-
tion between pericardial fat and baseline variables in patients
aseline Characteristics of Patients in Sinushythm and All Patient With Atrial FibrillationTable 1 B selin Characteristics of P tie ts in SinusRhythm and All Patients With Atrial Fibrillation
Sinus Rhythm
(n  76)
Atrial Fibrillation
(n  197) p Value
Pericardial fat, ml 76.1 36.3 101.6 44.1 0.001
Age, yrs 55.9 14.9 58.1 9.8 0.56
Male 43 (65) 141 (72) 0.36
Structural heart disease 23 (35) 76 (39) 0.39
Hypertension 31 (47) 101 (51) 0.55
Diabetes mellitus 12 (18) 16 (8) 0.02
LVEF, % 56.4 9.9 56.3 7.2 0.93
Left atrial diameter, mm 37.9 5.9 43.4 7.4 0.001
BMI, kg/m2 28.8 6.9 30.3 4.9 0.06alues are mean  SD or n (%).
BMI  body mass index; LVEF  left ventricular ejection fraction.
Vith AF. Multiple logistic regres-
ion was used to study the associ-
tion between AF and pericardial
at after correction for the baseline
ariables for the whole group.
ultivariate multinomial logistic
egression was used to examine the
ssociation between pericardial fat
nd both paroxysmal and persis-
ent AF compared with sinus
hythm. A p value0.05 was con-
idered statistically significant.
esults
aseline characteristics. A total of 273 patients were stud-
ed: 197 patients with AF and 76 controls with no history of
F (sinus rhythm group). The baseline characteristics of the
F and sinus rhythm groups are shown in Table 1. Within
he AF group, there were 126 patients with paroxysmal AF
nd 71 patients with persistent AF (Table 2).
As Figure 1A demonstrates, patients with AF had sig-
ificantly more pericardial fat compared with patients in
inus rhythm (101.6  44.1 ml vs. 76.1  36.3 ml, p 
.001). The volume of pericardial fat was significantly larger
n paroxysmal AF compared with sinus rhythm (93.9 
9.1 ml vs. 76.1  36.3 ml, p  0.02) (Fig. 1B). Similarly,
ersistent AF patients had a larger pericardial fat volume
ompared with patients who had paroxysmal AF (115.4 
9.3 ml vs. 93.9  39.1 ml, p  0.001) (Fig. 1B).
ericardial fat and AF. Multiple risk factors have been
ssociated with the development of AF, including age, hyper-
ension, valvular heart disease, LVEF, obesity and associated
bstructive sleep apnea, and LA enlargement. The results of
nivariate and multivariate linear regression analyses examin-
ng the association between pericardial fat volume and these
isk factors are shown in Table 3.
Pericardial fat was associated with AF (odds ratio [OR]:
.13; 95% confidence interval [CI]: 1.03 to 1.24, p  0.01),
Abbreviations
and Acronyms
AF  atrial fibrillation
BMI  body mass index
CI  confidence interval
CT  computed
tomography
LA  left atrial
LVEF  left ventricular
ejection fraction
OR  odds ratio
aseline Characteristics of Patients ininus Rhyt m, Paroxysmal AF, and Persistent AFTable 2 B seline Characteristics of Patients inSinus Rhythm, Paroxysmal AF, and Persistent AF
Sinus Rhythm
(n  76)
Paroxysmal AF
(n  126)
Persistent AF
(n  71) p Value
Pericardial fat, ml 76.1 36.3 93.9 39.1 115.4 49.3 0.001*
Age, yrs 55.9 14.9 58.3 9.7 57.8 10.4 0.34*
Male 43 (65) 82 (65) 59 (83) 0.02†
Structural heart
disease
16 (24) 43 (34) 33 (46) 0.16†
Hypertension 31 (46) 62 (49) 39 (55) 0.62†
Diabetes mellitus 12 (18) 12 (10) 4 (6) 0.05†
LVEF, % 56.4 9.9 57.5 5.7 54.7 8.7 0.15*
Left atrial
diameter, mm
37.9 5.9 41.4 6.9 46.6 7.0 0.001*
BMI, kg/m2 28.8 6.9 30.1 4.9 30.5 5.1 0.07*alues are mean  SD or n (%). *p value using analysis o
AF  atrial fibrillation; other abbreviations as in Table 1f variance. †p value using chi square.
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Pericardial Fat Related to Atrial Fibrillation August 31, 2010:784–8nd this relationship remained significant after adjusting for
F risk factors including age, sex, hypertension, valvular
eart disease, LVEF, diabetes mellitus, and BMI. The
ssociation between pericardial fat volume and AF was also
ndependent of LA enlargement (OR: 2.22, 95% CI: 1.04 to
.67, p  0.04) (Table 4).
Pericardial fat volume was associated with both paroxysmal
F (OR: 1.11, 95% CI: 1.01 to 1.23, p 0.04) and persistent
F (OR: 1.18, 95% CI: 1.05 to 1.33, p  0.004) and this
elationship was also completely independent of all the risk
actors (Table 5).
ericardial fat and LA size. Consistent with previous studies,
A size was larger in AF patients compared with sinus rhythm
43.4 7.4 mm vs. 37.9 5.9 mm, p 0.001) (Table 1) and
as independently associated with AF. Pericardial fat volume
orrelated with LA enlargement as measured by LA diameter
b 0.82; 95% CI: 0.08 to 1.56, p 0.03) and LA volume on
-dimensional echocardiography (b  0.27; 95% CI: 0.02 to
.55, p 0.05), as well as LA volume on CT (b  0.24; 95%
I: 0.04 to 0.45, p  0.02) (Fig. 2). The association between
Figure 1 Differences in Pericardial Fat Volume Among Patients
(A) Comparison of pericardial fat volume among patients with atrial fibrillation (AF)
(B) Comparison of pericardial fat volume among patients with persistent AF, parox
Univariate and Multivariate Linear Regression foAssoci ion Between Pericardial Fat (1 ml) andTable 3 Univariate and Multivariate Line r RAssociation Between Pericardial Fa
Univariate Linear R
b (95% CI)
Age, yrs 0.94 (0.48 to 1.40)
Sex, male 21.8 (9.8 to 32.4)
Structural heart disease 16.5 (5.16 to 27.8)
Hypertension 19.7 (9.3 to 30.1)
Diabetes mellitus 7.4 (24.7 to 9.7)
Left atrial diameter, mm 1.48 (0.76 to 2.19)
Body mass index, kg/m2 1.52 (0.55 to 2.50)
Ejection fraction, % 0.09 (0.62 to 0.79)CI  confidence interval.ericardial fat volume and AF was independent of LA enlarge-
ent. For every 10-ml increase in pericardial fat volume, the
dds of AF increase by 13%.
iscussion
his is the first study to examine the association between
ericardial fat and AF, demonstrating a significant associa-
ion with both paroxysmal and persistent AF that is com-
letely independent of all major risk factors including LA
nlargement.
ericardial fat, obesity, and AF. The relationship between
entral obesity and cardiovascular disease is well established (1).
ecently, attention has focused on visceral adipose tissue, such
s pericardial fat, because of its inflammatory and endocrine
roperties (2–5). In fact, the correlation between pericardial fat
nd metabolic risk is stronger than that of other indexes of
ystemic obesity such as BMI or waist circumference (11).
lthough multiple studies have demonstrated that overall
AF and Sinus Rhythm
atients who do not have a history of AF.
AF, and those who do not have a history of AF.
line Variablesssion for th
l) and Baseline Variables
ion Multivariate Linear Regression
p Value b (95% CI) p Value
0.001 0.83 (0.32 to 1.33) 0.001
0.001 22.7 (9.94 to 34.6) 0.001
0.004 10.4 (1.41 to 24.3) 0.08
0.001 12.8 (1.16 to 24.3) 0.03
0.39 14.4 (32.2 to 3.79) 0.12
0.001 0.82 (0.08 to 1.56) 0.03
0.002 1.71 (0.75 to 2.78) 0.001
0.82 0.38 (0.29 to 1.07) 0.27With
and p
ysmalr theBasegr
t (1 m
egress
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August 31, 2010:784–8 Pericardial Fat Related to Atrial Fibrillationbesity is associated with AF, ours is the first to examine the
elationship between AF and visceral adiposity (6–8,12).
ericardial fat, LA enlargement, and AF. LA enlarge-
ent is the final common end point of several different
rocesses leading to the development of AF, and is one of the
trongest predictors of its recurrence (13). Recent evidence has
emonstrated a possible relationship between pericardial fat
nd LA size (14,15); however, this is the first study to correlate
ericardial fat with LA size and risk of AF. Atrial enlargement
as traditionally been measured using 2-dimensional echocar-
iography, but this may not correlate well with true LA volume
easured by CT or magnetic resonance imaging (16). Accord-
ngly, LA size was measured by 3 different methods in this
tudy: 1) LA diameter on 2-dimensional echocardiography; 2)
A volume on 2-dimensional echocardiography; and 3) LA
olume measured by gated CT. Pericardial fat volume corre-
ated with LA size using all 3 methods. Since pericardial fat
olume is completely independent of LA size and other AF
isk factors, it may become an additional parameter to consider
hen assessing an individual patient’s risk of having AF.
ericardial fat, inflammation, and AF. Inflammation is
ssociated with AF; however, the exact mechanisms are
nclear (9,10). Pericardial adipose tissue is directly con-
iguous with atrial and ventricular myocardium, and it
eleases inflammatory cytokines that have been impli-
ultiple Logistic Regressionomparing Atrial Fibrillation to Sinus RhythmTable 4 Multiple Log stic Regre sionComparing Atrial Fibrillation to Sinus Rhythm
Odds Ratio (95% CI) p Value
Pericardial fat, 10 ml 1.13 (1.03–1.24) 0.01
Age, yrs 1.001 (0.96–1.04) 0.96
Sex, male 1.46 (0.68–3.02) 0.33
Structural heart disease 1.54 (0.68–3.48) 0.30
Hypertension 0.83 (0.41–1.92) 0.78
Diabetes mellitus 0.41 (0.15–1.06) 0.09
Left atrial diameter 42 mm 2.22 (1.04–4.67) 0.04
Body mass index, kg/m2 1.02 (0.95–1.08) 0.52
Ejection fraction, % 1.02 (0.98–1.07) 0.23
I  confidence interval.
Multivariate Multinomial Logistic RegressionComparing Paroxysmal and Persist nt AF to SinTable 5 ltivari te Multinomial Logistic RComparing Paroxysmal and Persiste
Paroxysm
Odds Ratio (95% CI)
Pericardial fat, 10 ml 1.11 (1.01–1.23)
Age, yrs 1.01 (0.95–1.04)
Sex, male 1.27 (0.58–2.78)
Structural heart disease 1.40 (0.61–3.29)
Hypertension 0.83 (0.37–1.86)
Diabetes mellitus 0.48 (0.16–1.34)
Ejection fraction, % 1.04 (0.97–1.09)
Left atrial diameter 42 mm 1.52 (0.68–3.38)
Body mass index, kg/m2 1.02 (0.93–1.09)
*In multinomial logistic regression, the paroxysmal atrial fibrillation (
group, which acts as a reference.
CI  confidence interval.ated in the genesis of coronary atherosclerosis and
ardiovascular disease risk factors (2–5). These local
nflammatory effects may provide a mechanism to explain
he association between AF and pericardial fat. This
ypothesis needs to be addressed in future studies.
tudy limitations. This study was not designed to address
hether increased pericardial fat is a cause or consequence of
F. Although the most likely mechanism involves inflamma-
ion, this needs to be proved in future studies. Computed
omography cannot distinguish epicardial fat separated by the
isceral pericardium. This study defined pericardial fat as all
dipose tissue within the pericardial sac, according to standard
ethodology (2,5,11,15).
Although baseline characteristics were well matched, one
annot exclude a difference other than the presence of AF
etween the groups. This study examined patients with symp-
omatic AF who had failed antiarrhythmic therapy and were
eferred for ablation. While this may introduce an element of
election bias, the findings are nonetheless valid and clinically
elevant. In addition, if the logistic regression model is over-
tted, it may not replicate well with larger datasets. However,
his study is the first to demonstrate an association between
ericardial fat and AF. Larger prospective studies are needed to
xtend this observation to other AF populations and clarify the
ature of the association.
This study did not formally test for obstructive sleep apnea.
owever, sleep apnea is highly correlated with central obesity,
nd this study carefully examined the BMI of all patients
nrolled. The relationship between pericardial fat and AF was
ndependent of BMI, and BMI was not independently corre-
ated with AF. Thus, it is extremely unlikely that sleep apnea
ccounts for the highly significant association between pericar-
ial fat and AF.
onclusions
ericardial fat is highly associated with paroxysmal and
ersistent AF independent of traditional AF risk factors,
ncluding LA enlargement. The nature of the role that
hythmsion
F to Sinus Rhythm
Persistent AF
p Value Odds Ratio (95% CI)* p Value
0.04 1.18 (1.05–1.33) 0.004
0.67 0.97 (0.94–1.02) 0.48
0.52 2.01 (0.76–5.35) 0.16
0.44 1.83 (0.71–4.74) 0.21
0.57 0.95 (0.38–2.38) 0.73
0.17 0.29 (0.07–1.22) 0.12
0.09 1.01 (0.95–1.06) 0.79
0.32 4.57 (1.85–11.3) 0.001
0.63 1.01 (0.93–1.09) 0.80
up and the persistent AF group are compared with the sinus rhythmus Regres
nt A
al AF
*
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Pericardial Fat Related to Atrial Fibrillation August 31, 2010:784–8ericardial fat plays in AF pathogenesis requires future
nvestigation.
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